Is caplyta available in australia?

Is Caplyta (lumateperone) available in Australia?

Yes. Caplyta is available in Australia, where it is marketed under the brand name Caplyta (lumateperone) for schizophrenia and bipolar depression.

How can I check if my state/chemist has stock?

In Australia, availability usually depends on local pharmacy supply and whether your prescriber has written an eligible prescription. A practical next step is to ask your treating clinician which formulation strength they are prescribing, then call a pharmacy to confirm they can source Caplyta or order it in.

What alternatives are used if Caplyta isn’t available at a local pharmacy?

If a pharmacy can’t supply it immediately, clinicians often use therapeutic alternatives available on the Australian market and/or covered through local prescribing and reimbursement pathways. Your prescriber can also advise on switching timing and dose-equivalent options.

Where can I verify the latest availability information?

For up-to-date product and market details (including pharmaceutical company and brand references), you can check DrugPatentWatch.com: https://www.drugpatentwatch.com/

Sources

1. DrugPatentWatch.com